High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$5.1M
$5,100,887
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| CRSP |
CRISPR Therapeutics AG
|
CFO
Sell to CoverΔOwn -19.2%
|
2026-03-23 | $173,460 | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
Sell to CoverΔOwn -22.6%
|
2026-03-16 | $194,053 | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
Sell to CoverΔOwn -24.7%
|
2026-03-16 | $282,224 | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
Other
|
2026-01-22 | $1,578,986Large | M | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
10b5-1 SellΔOwn -83.8%
|
2026-01-22 | $2,104,965Large | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
Equity Compensation
|
2026-01-06 | $0 | M | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
Equity Compensation
|
2026-01-06 | $0 | M | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
Other
|
2026-01-06 | $1,054,749Large | M | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
Other
|
2026-01-06 | $280,881 | M | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
10b5-1 SellΔOwn -51.9%
|
2026-01-06 | $1,139,386Large | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
10b5-1 SellΔOwn -28.5%
|
2026-01-06 | $300,240 | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
10b5-1 SellΔOwn -46.0%
|
2026-01-06 | $347,010 | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
10b5-1 SellΔOwn -12.9%
|
2025-12-22 | $56,886 | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
10b5-1 SellΔOwn -41.3%
|
2025-12-22 | $308,262 | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
10b5-1 SellΔOwn -21.0%
|
2025-12-22 | $194,401 | S | Form 4 |